A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern, E Caselli, N Grigorieff… - Journal of medicinal …, 2002 - ACS Publications
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
[引用][C] A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
SL McGovern, E Caselli, N Grigorieff… - Journal of Medicinal …, 2002 - cir.nii.ac.jp
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput
Screening | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Screening | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
SL Mcgovern, E Caselli, N Grigorieff… - JOURNAL OF …, 2002 - iris.unimore.it
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
[引用][C] A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL MCGOVERN, E CASELLI… - Journal of medicinal …, 2002 - pascal-francis.inist.fr
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput
screening CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
screening CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern, E Caselli… - Journal of medicinal …, 2002 - pubmed.ncbi.nlm.nih.gov
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
SL McGovern, E Caselli, N Grigorieff… - Journal of Medicinal …, 2002 - europepmc.org
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL Mcgovern, E Caselli, N Grigorieff… - Journal of Medicinal …, 2002 - hero.epa.gov
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
[引用][C] A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
SL McGovern, E Caselli, N Grigorieff… - Journal of Medicinal …, 2002 - infona.pl
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput
Screening × Close The Infona portal uses cookies, ie strings of text saved by a browser on the …
Screening × Close The Infona portal uses cookies, ie strings of text saved by a browser on the …
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern, E Caselli… - Journal of …, 2002 - mdanderson.elsevierpure.com
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …
[PDF][PDF] A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
SL McGovern, E Caselli, N Grigorieff… - Journal of Medicinal …, 2002 - academia.edu
High-throughput and virtual screening are widely used to discover novel leads for drug
design. On examination, many screening hits appear non-drug-like: they act …
design. On examination, many screening hits appear non-drug-like: they act …